This inventor holds 3 USPTO granted patents. Top assignees: University of Arkansas, Other. Active years: 2010-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 851 
1 out of 834,601 Years Active: 2010-2017
Title: Innovations in Cancer Immunotherapy by Kristina L Bondurant
Introduction
Kristina L Bondurant is a notable inventor based in Little Rock, AR (US), recognized for her contributions to cancer immunotherapy. With a total of 3 patents, she has made significant strides in developing innovative treatments that harness the body's immune system to combat cancer.
Latest Patents
One of her latest patents is focused on multi-epitope peptide-loaded dendritic cell immunotherapy for cancer. This invention describes peptides ranging from about 7 to about 50 amino acid residues in length that have epitopes binding to multiple HLA class II proteins. These peptides stimulate CD4+ T cells for cancer treatment, particularly targeting serine proteases overexpressed in ovarian cancer and other malignancies. The versatility of these peptides allows for treatment across diverse patient populations with varying HLA class II alleles. Another significant patent involves immunotherapeutic methods targeting stratum corneum chymotryptic enzyme (SCCE), which is specifically over-expressed in ovarian and other malignancies. This invention highlights the potential of SCCE peptides in inducing immune responses and developing immunotherapies for these cancers.
Career Highlights
Kristina has worked at the University of Arkansas, where she has contributed to research and development in the field of immunotherapy. Her work has been pivotal in advancing the understanding of how specific peptides can be utilized to enhance immune responses against cancer cells.
Collaborations
Throughout her career, Kristina has collaborated with esteemed colleagues, including Martin J Cannon and Timothy J O'Brien. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas in cancer research.
Conclusion
Kristina L Bondurant's work in cancer immunotherapy exemplifies the impact of innovative thinking in the medical field. Her patents and research contributions are paving the way for new treatment options that could significantly improve patient outcomes in cancer therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile